Gentian Diagnostics ASA (OSL:GENT)

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 51.07M NOK in the quarter ending September 30, 2026, with 22.07% growth. This brings the company's total for the last twelve months to 191.35M, up 10.92% year-over-year. In the year 2025, Gentian Diagnostics ASA had annual revenue of 176.50M with 16.07% growth. That makes Gentian Diagnostics ASA the 33,688th largest company in the world by revenue and 197th in Norway.

• Revenue (ttm): 191.35M
• Revenue Growth: +10.92%
• P/S Ratio: 3.23
• Revenue / Employee: 2.99M
• Employees: 64
• Market Cap: 618.34M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe 114.18M 64.7%
• Asia 32.88M 18.6%
• USA 29.44M 16.7%

Fiscal year ended Dec 31, 2025 See the full Gentian Diagnostics ASA breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	176.50M	24.43M	16.07%
Dec 31, 2024	152.07M	16.92M	12.52%
Dec 31, 2023	135.15M	23.23M	20.76%
Dec 31, 2022	111.92M	11.91M	11.91%
Dec 31, 2021	100.01M	21.13M	26.78%
Dec 31, 2020	78.88M	23.50M	42.43%
Dec 31, 2019	55.38M	3.36M	6.47%
Dec 31, 2018	52.02M	17.03M	48.68%
Dec 31, 2017	34.99M	4.09M	13.24%
Dec 31, 2016	30.90M	5.31M	20.75%
Dec 31, 2015	25.59M	1.03M	4.21%
Dec 31, 2014	24.55M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error